Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
| Actual shortage: | 240 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184922 |
| TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183367 |
| TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183416 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184925 |
| TEVA-FLUTICASONE | 50MCG | METERED-DOSE PUMP | Resolved | 2023-02-16 | 2023-04-28 | 184928 |
| TEVA-LORAZEPAM | 1MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163912 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163918 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2022-09-22 | 2023-04-28 | 169973 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174613 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2022-12-08 | 2023-04-28 | 177523 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
| TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-02-02 | 2023-04-28 | 183401 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |